United States · Bill · HR
H.R. 8038 (117th)
Formula Shortage Reporting Act of 2022
Introduced
13 June 2022
Last action
13 June 2022 · Introduced
Status
Referred to the House Committee on Energy and Commerce.
Sponsors
Dusty Johnson, Abigail Spanberger, Stephanie Bice, Kim Schrier
Subjects
Healthcare
Source updated
3 January 2025
Summary
Formula Shortage Reporting Act of 2022 This bill requires manufacturers of infant formula to notify the Food and Drug Administration (FDA) at least 72 hours in advance of a manufacturing interruption or product discontinuance that is expected to meaningfully disrupt the product's supply. The FDA must post such information on its website and notify health care providers.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 June 2022
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
13 June 2022
Introduced
Introduced in House
Source: IntroReferral
13 June 2022
Introduced
Introduced in House
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in House · 13 June 2022 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 13 June 2022
Introduced in House (PDF)
Introduced in House · EN · 13 June 2022
Introduced in House
summary · EN · 13 June 2022
Sponsors
- Dusty Johnson · R · Sponsor
- Abigail Spanberger · D · Sponsor
- Stephanie Bice · R · Sponsor
- Kim Schrier · D · Sponsor
- · hsif00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/8038
- Open data entity: https://api.congress.gov/v3/bill/117/hr/8038
- us · 117-hr-8038 · source updated 3 January 2025